Tenet Healthcare Corporation (THC)
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Tenet Healthcare is currently shifting towards a more stable demand for high-acuity service. The company is committed to continued expansion and allocated yearly budget to improve its Ambulatory Care Services. Posted an improving margin and has positive outlook from the management.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Will McDowell – Vice President-Investor Relations Saum Sutaria – Chairman and Chief Executive Officer Sun Park – Executive Vice President and Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research Ben Hendrix – RBC Capital Markets A.J. Rice – UBS Stephen Baxter – Wells Fargo Ann Hynes – Mizuho Michael Ha – Baird Pito Chickering – Deutsche Bank Justin Lake – Wolfe Research Joanna Gajuk – Bank of America Whit Mayo – Leerink Partners Andrew Mok – Barclays Brian Tanquilut – Jefferies Matthew Gillmor – KeyBanc Capital Markets Sarah James – Cantor Fitzgerald John Ransom – Raymond James Jamie Perse – Goldman Sachs Operator Good morning, and welcome to Tenet Healthcare's Third Quarter 2024 Earnings Conference Call.
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tenet Healthcare (THC) Beats Q3 Earnings and Revenue Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $1.44 per share a year ago.
Stay Ahead of the Game With Tenet (THC) Q3 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
A Dose of Growth? Why Tenet Healthcare Could be a Buy Pre-Q3 Earnings
THC's third-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing
In the latest trading session, Tenet Healthcare (THC) closed at $163.87, marking a +1.34% move from the previous day.
Bargain or Bust? Decoding Tenet Healthcare Stock's Lower Valuation
THC is well-positioned to benefit from the growing demand for hospital services. Yet, rising costs can potentially squeeze its margin growth.
